The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy
After an ectopic pregnancy (EP) fertility decreases, mostly due to tubal factor. Hysterosalpingography (HSG) is the most cost-effective tool for tubal patency assessment. Objective. To evaluate the usefulness of a HSG after a medical treatment for an EP, in order to counsel women on the most appropr...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Obstetrics and Gynecology International |
| Online Access: | http://dx.doi.org/10.1155/2011/547946 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832568072133672960 |
|---|---|
| author | Emma Garcia Grau Miguel Ángel Checa Vizcaíno Mário Oliveira Judith Lleberia Juanós Ramon Carreras Collado Yolanda Canet Estevez |
| author_facet | Emma Garcia Grau Miguel Ángel Checa Vizcaíno Mário Oliveira Judith Lleberia Juanós Ramon Carreras Collado Yolanda Canet Estevez |
| author_sort | Emma Garcia Grau |
| collection | DOAJ |
| description | After an ectopic pregnancy (EP) fertility decreases, mostly due to tubal factor. Hysterosalpingography (HSG) is the most cost-effective tool for tubal patency assessment. Objective. To evaluate the usefulness of a HSG after a medical treatment for an EP, in order to counsel women on the most appropriate way to conceive future pregnancies. Methods. Between 1998 and 2008, 144 patients were submitted to medical treatment for an EP and performed HSG 3 months after the event. Results. 72.2% of normal HSG, 18.8% with unilateral obstruction, 6.3% tubal patency with defect, and 2.8% bilateral obstruction. Conclusion. Routine HSG following medical treatment for an EP does not seem necessary, as it does not change the initial management in 97.2% of the cases, but might be considered in selected risk cases, permitting timely referral of patients to in vitro fertilization. |
| format | Article |
| id | doaj-art-4b30dfd504724415b4b563f970310588 |
| institution | Kabale University |
| issn | 1687-9589 1687-9597 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Obstetrics and Gynecology International |
| spelling | doaj-art-4b30dfd504724415b4b563f9703105882025-02-03T00:59:47ZengWileyObstetrics and Gynecology International1687-95891687-95972011-01-01201110.1155/2011/547946547946The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic PregnancyEmma Garcia Grau0Miguel Ángel Checa Vizcaíno1Mário Oliveira2Judith Lleberia Juanós3Ramon Carreras Collado4Yolanda Canet Estevez5Department of Obstetrics and Gynecology, Corporació Sanitària Parc Taulí, 08208 Sabadell, Barcelona, SpainDepartment of Obstetrics and Gynecology, Hospital Universitari del Mar, Universitat Autònoma de Barcelona, 08003 Barcelona, SpainLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, 4710-057 Braga, PortugalDepartment of Obstetrics and Gynecology, Corporació Sanitària Parc Taulí, 08208 Sabadell, Barcelona, SpainDepartment of Obstetrics and Gynecology, Hospital Universitari del Mar, Universitat Autònoma de Barcelona, 08003 Barcelona, SpainDepartment of Obstetrics and Gynecology, Corporació Sanitària Parc Taulí, 08208 Sabadell, Barcelona, SpainAfter an ectopic pregnancy (EP) fertility decreases, mostly due to tubal factor. Hysterosalpingography (HSG) is the most cost-effective tool for tubal patency assessment. Objective. To evaluate the usefulness of a HSG after a medical treatment for an EP, in order to counsel women on the most appropriate way to conceive future pregnancies. Methods. Between 1998 and 2008, 144 patients were submitted to medical treatment for an EP and performed HSG 3 months after the event. Results. 72.2% of normal HSG, 18.8% with unilateral obstruction, 6.3% tubal patency with defect, and 2.8% bilateral obstruction. Conclusion. Routine HSG following medical treatment for an EP does not seem necessary, as it does not change the initial management in 97.2% of the cases, but might be considered in selected risk cases, permitting timely referral of patients to in vitro fertilization.http://dx.doi.org/10.1155/2011/547946 |
| spellingShingle | Emma Garcia Grau Miguel Ángel Checa Vizcaíno Mário Oliveira Judith Lleberia Juanós Ramon Carreras Collado Yolanda Canet Estevez The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy Obstetrics and Gynecology International |
| title | The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy |
| title_full | The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy |
| title_fullStr | The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy |
| title_full_unstemmed | The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy |
| title_short | The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy |
| title_sort | value of hysterosalpingography following medical treatment with methotrexate for ectopic pregnancy |
| url | http://dx.doi.org/10.1155/2011/547946 |
| work_keys_str_mv | AT emmagarciagrau thevalueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT miguelangelchecavizcaino thevalueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT mariooliveira thevalueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT judithlleberiajuanos thevalueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT ramoncarrerascollado thevalueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT yolandacanetestevez thevalueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT emmagarciagrau valueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT miguelangelchecavizcaino valueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT mariooliveira valueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT judithlleberiajuanos valueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT ramoncarrerascollado valueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy AT yolandacanetestevez valueofhysterosalpingographyfollowingmedicaltreatmentwithmethotrexateforectopicpregnancy |